Alignment Healthcare (ALHC) just reported a profitable first quarter, with revenue of US$1,235.2 million, net income of US$11.42 million, and earnings per share ahead of expectations, while also raising its full-year revenue guidance.

Despite the strong first quarter profit and higher full year guidance, Alignment Healthcare’s recent share price has been volatile, with a 1 day share price return of a 10.12% decline but a 1 year total shareholder return of 30.46% and a 3 year total shareholder return of 194.05%. This suggests that longer term momentum has been stronger than the latest swing.

If this kind of earnings driven move has your attention, it can be a good moment to see what else is happening across healthcare AI, starting with 33 healthcare AI stocks

With Alignment Healthcare now profitable, trading at US$20.26 and sitting at a 26% discount to the average analyst price target and a 51% discount to one intrinsic value estimate, the key question is whether there is still an investment opportunity here or if the market is already reflecting expectations for future growth.

Most Popular Narrative: 20.5% Undervalued

At a last close of $20.26 versus a narrative fair value of $25.50, Alignment Healthcare is framed as undervalued, with that gap resting heavily on growth and margin assumptions.

Alignment's robust, technology-enabled care model and investments in administrative automation, workflow standardization, and digital health platforms position the company to significantly lower SG&A expenses and improve scalability, likely powering both margin expansion and earnings growth over the next several years. Ongoing expansion into existing counties and new states, combined with low market penetration and favorable demographic trends from a rapidly aging population, create a long-term runway for outsized membership and revenue growth as the Medicare-eligible population swells.

Want to see what sits behind that growth runway and margin uplift story? The narrative leans on fast compounding revenue, rising profitability, and a rich future earnings multiple.

Result: Fair Value of $25.50 (UNDERVALUED)

However, this hinges on Medicare Advantage policies and competition, where tighter reimbursement or slower membership growth could quickly challenge the margin recovery and earnings narrative.

Next Steps

If this mix of enthusiasm and caution has you thinking, it can help to look at the numbers yourself and move quickly while the information is fresh. To weigh both sides of the story in one place, review the 5 key rewards and 1 important warning sign

Looking for more investment ideas?

Before you move on, give yourself a chance to spot a few fresh ideas that might fit your goals just as well, or even better.

• Target quality at a discount by scanning 50 high quality undervalued stocks that combine solid fundamentals with appealing valuations.
• Prioritize resilience by reviewing 69 resilient stocks with low risk scores that aim to keep downside risk in check.
• Get ahead of the crowd by searching through a screener containing 25 high quality undiscovered gems before they are widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.